{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:18:00Z","timestamp":1790432280984,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T00:00:00Z","timestamp":1471132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.curtheres.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T20:24:30Z","timestamp":1484943870000},"page":"e1-e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study"],"prefix":"10.1016","volume":"84","author":[{"given":"Seth K.","family":"Amponsah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George O.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel","family":"Enweronu-Laryea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwasi A.","family":"Bugyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosta","family":"Hadji-Popovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgen A.L.","family":"Kurtzhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.curtheres.2017.01.001_bib1","first-page":"17","article-title":"Antibiotic use in neonatal sepsis","volume":"40","author":"Yurdakok","year":"1998","journal-title":"Turk J Pediatr"},{"issue":"7","key":"10.1016\/j.curtheres.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/cbic.200900779","article-title":"The future of aminoglycosides: The end or renaissance?","volume":"11","author":"Houghton","year":"2010","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.curtheres.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2125.2005.02530.x","article-title":"Limited predictability of amikacin clearance in extreme premature neonates at birth","volume":"61","author":"Allegaert","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.curtheres.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00228-009-0637-4","article-title":"Individualized dosing of amikacin in neonates: a pharmacokinetic\/pharmacodynamic analysis","volume":"65","author":"Sherwin","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.curtheres.2017.01.001_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002280050389","article-title":"Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models","volume":"53","author":"Botha","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.curtheres.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/AAC.46.5.1381-1387.2002","article-title":"Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants and children","volume":"46","author":"Treluyer","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.curtheres.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/FTD.0b013e31818b6b2f","article-title":"Suboptimal aminoglycoside dosing in critically ill patients","volume":"30","author":"Rea","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.curtheres.2017.01.001_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-642-13443-2_15","article-title":"Methylxanthines and the kidney","volume":"200","author":"Osswald","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"10.1016\/j.curtheres.2017.01.001_bib9","first-page":"136","article-title":"Changing pattern of bacterial isolates and antimicrobial susceptibility in neonatal infections in Korle-Bu Teaching Hospital, Ghana","volume":"84","author":"Enweronu-Laryea","year":"2007","journal-title":"East Afr Med J"},{"issue":"3","key":"10.1016\/j.curtheres.2017.01.001_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(05)82056-6","article-title":"New Ballard Score, expanded to include extremely premature infants","volume":"119","author":"Ballard","year":"1991","journal-title":"J Pediatr"},{"issue":"Part 1","key":"10.1016\/j.curtheres.2017.01.001_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/000456329202900104","article-title":"Particle enhanced light scattering immunoassay","volume":"29","author":"Newman","year":"1992","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/j.curtheres.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","article-title":"Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions","volume":"11","author":"Savic","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.curtheres.2017.01.001_bib13","article-title":"NONMEM Users Guide. Introduction to NONMEM 7.3.0","author":"Bauer","year":"2014","journal-title":"Icon Development Solutions, Hanover, MD"},{"issue":"5","key":"10.1016\/j.curtheres.2017.01.001_bib14","first-page":"486","article-title":"Therapeutic drug monitoring of amikacin in preterm and term infants","volume":"50","author":"Khan","year":"2009","journal-title":"Singapore Med J"},{"issue":"10","key":"10.1016\/j.curtheres.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01157-15","article-title":"Prospective evaluation of a model-based dosing regimen for amikacin in preterm and term neonates in clinical practice","volume":"59","author":"Smits","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.curtheres.2017.01.001_bib16","first-page":"e38","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT: Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"10.1016\/j.curtheres.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/AAC.34.2.265","article-title":"Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant","volume":"34","author":"Kenyon","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.curtheres.2017.01.001_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1985.245","article-title":"A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn","volume":"38","author":"Koren","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.01.001_bib19","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF01428387","article-title":"Population kinetics of gentamicin in neonates","volume":"44","author":"Weber","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2017.01.001_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/clinchem\/32.5.721","article-title":"Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity","volume":"32","author":"Warner","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.curtheres.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1651-2227.1989.tb11280.x","article-title":"Postnatal weight loss in preterm neonates less than 1500 g is due to isotonic dehydration of the extracellular volume","volume":"360","author":"Bauer","year":"1989","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"10.1016\/j.curtheres.2017.01.001_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cpt197620159","article-title":"Kinetics and dose calculations of amikacin in the newborn","volume":"20","author":"Sardemann","year":"1976","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.curtheres.2017.01.001_bib23","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2174\/138920111798808248","article-title":"Physiological changes in the critically ill patient with sepsis","volume":"12","author":"Hosein","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.curtheres.2017.01.001_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00005373-199404000-00002","article-title":"Generalized vascular permeability and pulmonary function in patients following serious trauma","volume":"36","author":"Gosling","year":"1994","journal-title":"J Trauma"},{"issue":"2","key":"10.1016\/j.curtheres.2017.01.001_bib25","first-page":"157","article-title":"Bacterial concentration and blood volume required for a positive blood culture","volume":"15","author":"Brown","year":"1995","journal-title":"J Perinatol"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X16300765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X16300765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:30:03Z","timestamp":1601368203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X16300765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":25,"alternative-id":["S0011393X16300765"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2017.01.001","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}